Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CpG ImmunoPharmaceuticals GmbH

Division of Pfizer Inc.

Latest From CpG ImmunoPharmaceuticals GmbH

CpG ImmunoPharmaceuticals Inc.

Pharmaceuticals; DNA Immunotherapeutics. A particular DNA sequence, cytosine followed by guanine (CpG) common in bacterial and viral DNA and rare in human DNA may produce therapeutic immune responses in humans. CpG ImmunoPharmaceuticals is developing a vaccine for hepatitis B, and a cancer adjuvant. CpG's DNA therapy may be applicable to a wide range of immunological disorders, from asthma to lupus.
BioPharmaceutical
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register